Immunovant Inc. (IMVT)
NASDAQ: IMVT
· Real-Time Price · USD
15.17
-0.09 (-0.59%)
At close: Aug 19, 2025, 9:43 AM
Immunovant Revenue
Immunovant reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending June 30, 2025, Immunovant generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
n/a
Price / Sales Ratio
0
Revenue / Employee
0
Employees
362
Market Cap
2.64B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Mar 31, 2025 | 0 | n/a |
| Mar 31, 2024 | 0 | n/a |
| Mar 31, 2023 | 0 | n/a |
| Mar 31, 2022 | 0 | n/a |
| Mar 31, 2021 | 0 | n/a |
| Mar 31, 2020 | 0 | n/a |
| Mar 31, 2019 | 0 | n/a |
| Mar 31, 2018 | 0 | n/a |